A detailed history of Financial Gravity Companies, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Financial Gravity Companies, Inc. holds 20,270 shares of NVO stock, worth $2.13 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
20,270
Holding current value
$2.13 Million
% of portfolio
0.65%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $2.41 Million - $2.95 Million
20,270 New
20,270 $2.41 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Financial Gravity Companies, Inc. Portfolio

Follow Financial Gravity Companies, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Companies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Companies, Inc. with notifications on news.